Inventor · disambiguated record
Stefan Knapp
Also filed as: KNAPP STEFAN
23 granted patents·4 pending applications·350 citations·filing 1990–2006
97Inventor score
Files withDADE BEHRING MARBURG GMBH20BEHRING DIAGNOSTICS GMBH3BEHRINGWERDE AKTIENGESELLSCHAF1BEHRINGWERKE AG1SIEMENS HEALTHCARE DIAGNOSTICS1
Top patents by PatentIndex Score
27 records- 0191US6531587B2Retrovirus from the HIV group and its useDADE BEHRING MARBURG GMBH·Filed 2001·Granted Mar 11, 2003·16 cites·13 claims
- 0290US6773915B2Retrovirus from the HIV group and its useDADE BEHRING MARBURG GMBH·Filed 2002·Granted Aug 10, 2004·13 cites·10 claims
- 0390US6551824B2Retrovirus from the HIV group and its useDADE BEHRING MARBURG GMBH·Filed 2001·Granted Apr 22, 2003·19 cites·22 claims
- 0488US6531137B2Retrovirus from the HIV group and its useDADE BEHRING MARBURG GMBH·Filed 2001·Granted Mar 11, 2003·16 cites·48 claims
- 0586US6528626B2Retrovirus from the HIV group and its useDADE BEHRING MARBURG GMBH·Filed 2001·Granted Mar 4, 2003·8 cites·67 claims
- 0686US5759770ARetrovirus from the HIV group and its useBEHRING DIAGNOSTICS GMBH·Filed 1995·Granted Jun 2, 1998·41 cites·20 claims
- 0784US5840480ARetrovirus from the HIV group and its useBEHRING DIAGNOSTICS GMBH·Filed 1995·Granted Nov 24, 1998·33 cites·11 claims
- 0882US6277561B1Diagnostic assay for detection of HIVDADE BEHRING MARBURG GMBH·Filed 1998·Granted Aug 21, 2001·28 cites·96 claims
- 0981US6974866B2Retrovirus from the HIV type O and its use (MVP-2901/94)DADE BEHRING MARBURG GMBH·Filed 2003·Granted Dec 13, 2005·11 cites·14 claims
- 1076US6548635B1Retrovirus from the HIV type O and its use (MVP-2901/94)DADE BEHRING MARBURG GMBH·Filed 2000·Granted Apr 15, 2003·6 cites·16 claims
- 1175US5159062ASignal peptide for the secretion of peptides in escherichia coliBEHRINGWERDE AKTIENGESELLSCHAF·Filed 1990·Granted Oct 27, 1992·39 cites·1 claims
- 1274US6869608B2Peptides derived from a retrovirus of the HIV group and their useDADE BEHRING MARBURG GMBH·Filed 2001·Granted Mar 22, 2005·5 cites·12 claims
- 1372US5830634APeptides derived from a retrovirus of the HIV group and their useDADE BEHRING MARBURG GMBH·Filed 1995·Granted Nov 3, 1998·21 cites·39 claims
- 1470US6335158B2Methodologies for the detection of human immunodeficiency virus nucleic acids employing oligonucleotide primer derived from the HIV-1 MVP5180/91 genomeDADE BEHRING MARBURG GMBH·Filed 1998·Granted Jan 1, 2002·14 cites·2 claims
- 1568US5770427ARetrovirus from the HIV group and its useBEHRING DIAGNOSTICS GMBH·Filed 1995·Granted Jun 23, 1998·16 cites·2 claims
- 1667US2007264627A1Retrovirus from the HIV group and its useDADE BEHRING MARBURG GMBH·Filed 2006·Application pending·0 cites
- 1767US2007105219A1Retrovirus from the HIV group and its useDADE BEHRING MARBURG GMBH·Filed 2006·Application pending·0 cites
- 1867US2005053920A1Retrovirus from the HIV group and its useDADE BEHRING MARBURG GMBH·Filed 2004·Application pending·0 cites
- 1962US6419925B1Toxoplasma gondii antigens, the preparation thereof and the use thereofDADE BEHRING MARBURG GMBH·Filed 2001·Granted Jul 16, 2002·1 cites·22 claims
- 2058US7803524B2Antigenic HIV gp41 chimeric polypeptides comprising the MVP5180/91 epitope SKGKLISSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2005·Granted Sep 28, 2010·0 cites·13 claims
- 2158US6120990AImmunochemical determination of multivalent analytesDADE BEHRING MARBURG GMBH·Filed 1998·Granted Sep 19, 2000·21 cites·21 claims
- 2251US6162631ARetrovirus from the HIV group and its use (MVP-2901/94)DADE BEHRING MARBURG GMBH·Filed 1997·Granted Dec 19, 2000·14 cites·6 claims
- 2349US6022546AToxoplasma gondii antigens, the preparation thereof and the use thereofDADE BEHRING MARBURG GMBH·Filed 1994·Granted Feb 8, 2000·6 cites·2 claims
- 2448US6326008B1Toxoplasma gondii antigens, the preparation thereof and the use thereofDADE BEHRING MARBURG GMBH·Filed 1999·Granted Dec 4, 2001·6 cites·5 claims
- 2546US5798205ARetrovirus from the HIV type O and its use (MVP-2901/94)DADE BEHRING MARBURG GMBH·Filed 1996·Granted Aug 25, 1998·11 cites·22 claims
- 2646US5580758ANucleic acid encoding a signal peptide, a recombinant molecule comprising the nucleic acid, methods of using the nucleic acid, and methods of using the signal peptideBEHRINGWERKE AG·Filed 1995·Granted Dec 3, 1996·5 cites·3 claims
- 2733US2004204477A1Interaction inhibitors of tcf-4 with beta-cateninFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefan Knapp files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →